Financial statements Apteka Centralna
Balance sheet data of APTEKA CENTRALNA
|
Year
|
2018
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|
| Total assets | 549 990,13 | 563 827,09 | 626 329,27 | 1 031 655,22 | 3 216 695,56 |
| A. Fixed assets | 1 903,92 | 429,92 | 0,00 | 0,00 | 444 326,62 |
| B. Current assets | 548 086,21 | 563 397,17 | 626 329,27 | 1 031 655,22 | 2 772 368,94 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 549 990,13 | 563 827,09 | 626 329,27 | 1 031 655,22 | 3 216 695,56 |
| A. Equity | -52 986,35 | -1 166,65 | 136 448,93 | 419 887,92 | 551 989,93 |
| B. Liabilities and provisions for liabilities | 602 976,48 | 564 993,74 | 489 880,34 | 611 767,30 | 2 664 705,63 |
| I. Long-term liabilities | 0,00 | 0,00 | 9 000,00 | 20 250,00 | 1 140 000,00 |
| II. Short-term liabilities | 481 015,37 | 512 291,84 | 414 939,71 | 591 517,30 | 1 478 196,25 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.